BARCLAYS PLC - 4D MOLECULAR THERAPEUTICS IN ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$941
-63.4%
73,935
-48.1%
0.00%
-50.0%
Q2 2023$2,574
+161.6%
142,464
+148.9%
0.00%
Q1 2023$984
+27.8%
57,229
+65.1%
0.00%
Q4 2022$770
-99.2%
34,673
+204.8%
0.00%
Q3 2022$91,000
+33.8%
11,376
+18.3%
0.00%
Q2 2022$68,000
-62.4%
9,616
-19.6%
0.00%
Q1 2022$181,00011,9560.00%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 377,777$15,659,0005.43%
BVF INC/IL 1,106,070$45,847,0001.80%
Eagle Health Investments LP 50,000$2,073,0001.33%
Ally Bridge Group (NY) LLC 150,000$6,218,0001.07%
Casdin Capital, LLC 780,555$32,354,0000.96%
VIKING GLOBAL INVESTORS LP 3,937,914$163,227,0000.45%
Pinz Capital Management, LP 19,900$825,0000.38%
ArrowMark Colorado Holdings LLC 1,063,744$44,092,0000.34%
Perceptive Advisors 600,256$24,881,0000.27%
ACUTA CAPITAL PARTNERS, LLC 20,000$829,0000.23%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders